UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.
HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.
Forty-nine bodies, likely of migrants, were found in two mass graves in Libya, according to the UN agency, the International Office of Migration.
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Indians are struggling to maintain a balance between digital workplace and life, with just three out of 100 individuals, according to a survey,.
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
HQ Team February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%.
Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in.
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.